WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), currently valued at $535 million, announced positive results from the Phase 2 VERONA clinical trial of DURAVYU™, its ...

Good' (HDL) cholesterol, usually considered to be beneficial for health, may be linked to a heightened risk of the serious ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

Dr Shonraj Ballae, PhD, Head of Clinical Research, Remidio shares all you need to know Remidio has pioneered the development ...

Highlighting the event is the immersive simulation, “Seeing Beyond the Ordinary and Repairing Damages,” led by world-renowned ...

The innovation caters to enhanced clinical flexibility and precision, addressing unique diagnostic needs in the Fluorescein Angiography Market, particularly for patients requiring specialized ...

As an Amazon Associate I earn from qualifying purchases. This Keto Vanilla Cake is the most delicious, moist, and buttery diabetic-friendly birthday cake. Plus, this vanilla keto cake has a dairy-free ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and underserved regions where access to retina specialists is limited. By automating ...

This code is designed for detecting Diabetic Retinopathy in retinal fundus images using a deep learning approach. It preprocesses the images, applies data augmentation to improve model generalization, ...